Involvement of Annexin V in Antiproliferative Effects of Gonadotropin-Releasing Hormone Agonists on Human Endometrial Cancer Cell Line

By Shibata S.   Sato H.   Ota H.   Karube A.   Takahashi O.   Tanaka T.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 217-221

Elsevier

Access to resources Recommend Favorite

Luteinizing Hormone-Releasing Hormone Agonist Triptorelin and Antagonist Cetrorelix Inhibit EGF-Induced c-fos Expression in Human Gynecological Cancers

By Grundker C.   Volker P.   Schulz K.-D.   Emons G.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 194-202

Elsevier

Access to resources Recommend Favorite

Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro

By Jaszberenyi Miklos   Schally Andrew   Block Norman   Zarandi Marta   Cai Ren-Zhi   Vidaurre Irving   Szalontay Luca   Jayakumar Arumugam   Rick Ferenc  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 281-290

Springer Publishing Company

Access to resources Recommend Favorite

Cell Cycle Arrest in Endometrial Carcinoma Cells Exposed to Gonadotropin-Releasing Hormone Analog

By Kim J.W.   Lee Y.S.   Kim B.K.   Park D.C.   Lee J.M.   Kim I.K.   Namkoong S.E.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 368-371

Elsevier

Access to resources Recommend Favorite

Antineoplastic Action of Growth Hormone-Releasing Hormone (GHRH) Antagonists

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 56-63

Bentham Science Publishers

Access to resources Recommend Favorite